ConductScience.org, home
Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Deep Vein Thrombosis - The EINSTEIN DVT Study
API referenceFor AI assistants

Trial · NCT00440193

Adverse events814

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 814

Download this page as JSON
TypeEventOrgan systemGroupAffectedAt riskEvents
otherNasopharyngitisInfections and infestationsRivaroxaban (Xarelto, BAY59-7939)1001,718
otherNasopharyngitisInfections and infestationsEnoxaparin/VKA911,711
otherHeadacheNervous system disordersRivaroxaban (Xarelto, BAY59-7939)911,718
otherHeadacheNervous system disordersEnoxaparin/VKA701,711
otherEpistaxisRespiratory, thoracic and mediastinal disordersRivaroxaban (Xarelto, BAY59-7939)901,718
otherEpistaxisRespiratory, thoracic and mediastinal disordersEnoxaparin/VKA741,711
seriousAnaemiaBlood and lymphatic system disordersRivaroxaban (Xarelto, BAY59-7939)111,718
seriousAnaemiaBlood and lymphatic system disordersEnoxaparin/VKA81,711
seriousFebrile neutropeniaBlood and lymphatic system disordersRivaroxaban (Xarelto, BAY59-7939)11,718
seriousFebrile neutropeniaBlood and lymphatic system disordersEnoxaparin/VKA01,711
seriousLymphadenopathy mediastinalBlood and lymphatic system disordersRivaroxaban (Xarelto, BAY59-7939)01,718
seriousLymphadenopathy mediastinalBlood and lymphatic system disordersEnoxaparin/VKA11,711
seriousMicrocytic anaemiaBlood and lymphatic system disordersRivaroxaban (Xarelto, BAY59-7939)11,718
seriousMicrocytic anaemiaBlood and lymphatic system disordersEnoxaparin/VKA01,711
seriousNormochromic normocytic anaemiaBlood and lymphatic system disordersRivaroxaban (Xarelto, BAY59-7939)11,718
seriousNormochromic normocytic anaemiaBlood and lymphatic system disordersEnoxaparin/VKA01,711
seriousSplenic haemorrhageBlood and lymphatic system disordersRivaroxaban (Xarelto, BAY59-7939)01,718
seriousSplenic haemorrhageBlood and lymphatic system disordersEnoxaparin/VKA11,711
seriousThrombocytopeniaBlood and lymphatic system disordersRivaroxaban (Xarelto, BAY59-7939)21,718
seriousThrombocytopeniaBlood and lymphatic system disordersEnoxaparin/VKA11,711

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00440193/events

API referenceFor AI assistants